Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 4Breast Neoplasms 3Melanoma 2Colorectal Neoplasms 2Untreated Resectable Pancreatic Adenocarcinoma 1Resectable Localized Prostate Cancer 1Prostatic Neoplasms 1Prostate Cancer Recurrent 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Neoplasm, Residual 1Liver Neoplasms 1Klatskin Tumor 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Glioma 1Gastrointestinal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Hydroxychloroquine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resectable Localized Prostate Cancer × Hydroxychloroquine × 1 year × Clear all
NCT06408298 2026-02-04

HCQ in Resectable Localized Prostate Cancer

Dartmouth-Hitchcock Medical Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
Genitourinary

Resectable Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡